These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 21530427)
1. Beclomethasone dipropionate: a second chance for topical steroids as maintenance therapy in ileal Crohn's disease. Billioud V; Peyrin-Biroulet L Dig Liver Dis; 2011 Jun; 43(6):423-4. PubMed ID: 21530427 [No Abstract] [Full Text] [Related]
2. Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial. Prantera C; Rizzi M; Cottone M; Casa A; Annese V; Sturniolo GC; Marconi S; Lochs H Dig Liver Dis; 2011 Jun; 43(6):459-64. PubMed ID: 21215714 [TBL] [Abstract][Full Text] [Related]
3. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease. Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study. Astegiano M; Pagano N; Sapone N; Simondi D; Bertolusso L; Bresso F; Demarchi B; Pellicano R; Bonardi R; Marconi S; Rizzetto M Biomed Pharmacother; 2007 Jul; 61(6):370-6. PubMed ID: 17399941 [TBL] [Abstract][Full Text] [Related]
5. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Campieri M Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332 [TBL] [Abstract][Full Text] [Related]
6. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496 [TBL] [Abstract][Full Text] [Related]
7. Oral locally active steroids in inflammatory bowel disease. Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947 [TBL] [Abstract][Full Text] [Related]
8. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Sandborn WJ; Feagan BG; Lichtenstein GR Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506 [TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Borgaonkar M; MacIntosh D; Fardy J; Simms L Cochrane Database Syst Rev; 2015 Feb; (2):CD000299. PubMed ID: 25674775 [No Abstract] [Full Text] [Related]
11. Adalimumab in steroid-dependent Crohn's disease patients: prognostic factors for clinical benefit. Orlando A; Renna S; Mocciaro F; Cappello M; Di Mitri R; Randazzo C; Cottone M Inflamm Bowel Dis; 2012 May; 18(5):826-31. PubMed ID: 21837774 [TBL] [Abstract][Full Text] [Related]
12. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517 [TBL] [Abstract][Full Text] [Related]
13. Beclomethasone dipropionate in microscopic colitis: Results of an exploratory open-label multicentre study (COLCO). Corte T; Janssens E; D'Hondt A; Thorrez K; Arts J; Dejaegher K; D'Heygere F; Holvoet A; van Besien B; Harlet L; Peeters H; Moerkercke WV; Baert F United European Gastroenterol J; 2019 Nov; 7(9):1183-1188. PubMed ID: 31700631 [TBL] [Abstract][Full Text] [Related]
14. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma. Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS Drugs; 1975; 10(3):166-210. PubMed ID: 172309 [TBL] [Abstract][Full Text] [Related]
15. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809 [TBL] [Abstract][Full Text] [Related]
16. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone. D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. Feagan BG; Sandborn WJ; Mittmann U; Bar-Meir S; D'Haens G; Bradette M; Cohen A; Dallaire C; Ponich TP; McDonald JW; Hébuterne X; Paré P; Klvana P; Niv Y; Ardizzone S; Alexeeva O; Rostom A; Kiudelis G; Spleiss J; Gilgen D; Vandervoort MK; Wong CJ; Zou GY; Donner A; Rutgeerts P JAMA; 2008 Apr; 299(14):1690-7. PubMed ID: 18398081 [TBL] [Abstract][Full Text] [Related]
18. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529 [TBL] [Abstract][Full Text] [Related]
20. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease. Rutgeerts P Mediators Inflamm; 1998; 7(3):137-40. PubMed ID: 9705597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]